OMS pede transparência da indústria farmacêutica no relato dos dados de estudos clínicos.

WHO Calls For Pharma Transparency In Clinical Trial Data Reporting – Health Policy Watch

Diretriz WHO: Joint Statement on transparency and data integrity International Coalition of Medicines Regulatory Authorities (ICMRA) and WHO

Comentário no Twitter

Wide and open access to clinical data for new medicines and vaccines will help build trust and the expand access @WHO @US_FDA @EMA_News @CDSCO_INDIA_INF @MoHFW_INDIA @ICMRDELHI @JeremyFarrar @Chikwe_I @jarottingen @pahowho https://t.co/1OACILbdh6

— Soumya Swaminathan (@doctorsoumya) May 7, 2021